Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Flow induces epithelial-mesenchymal transition, cellular heterogeneity and biomarker modulation in 3D ovarian cancer nodules.

Rizvi I, Gurkan UA, Tasoglu S, Alagic N, Celli JP, Mensah LB, Mai Z, Demirci U, Hasan T.

Proc Natl Acad Sci U S A. 2013 May 28;110(22):E1974-83. doi: 10.1073/pnas.1216989110. Epub 2013 May 3.

2.

Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells.

Comamala M, Pinard M, Thériault C, Matte I, Albert A, Boivin M, Beaudin J, Piché A, Rancourt C.

Br J Cancer. 2011 Mar 15;104(6):989-99. doi: 10.1038/bjc.2011.34. Epub 2011 Feb 15.

3.

Mesenchymal transformation in epithelial ovarian tumor cells expressing epidermal growth factor receptor variant III.

Zeineldin R, Rosenberg M, Ortega D, Buhr C, Chavez MG, Stack MS, Kusewitt DF, Hudson LG.

Mol Carcinog. 2006 Nov;45(11):851-60.

PMID:
16788982
4.

Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.

Jiang H, Lin X, Liu Y, Gong W, Ma X, Yu Y, Xie Y, Sun X, Feng Y, Janzen V, Chen T.

Mol Med. 2012 Oct 24;18:1197-208. doi: 10.2119/molmed.2012.00075.

5.

Ascites-induced shift along epithelial-mesenchymal spectrum in ovarian cancer cells: enhancement of their invasive behavior partly dependant on αv integrins.

Carduner L, Leroy-Dudal J, Picot CR, Gallet O, Carreiras F, Kellouche S.

Clin Exp Metastasis. 2014 Aug;31(6):675-88. doi: 10.1007/s10585-014-9658-1. Epub 2014 Jun 20.

PMID:
24946950
6.

VAV1 represses E-cadherin expression through the transactivation of Snail and Slug: a potential mechanism for aberrant epithelial to mesenchymal transition in human epithelial ovarian cancer.

Wakahashi S, Sudo T, Oka N, Ueno S, Yamaguchi S, Fujiwara K, Ohbayashi C, Nishimura R.

Transl Res. 2013 Sep;162(3):181-90. doi: 10.1016/j.trsl.2013.06.005. Epub 2013 Jul 12.

PMID:
23856093
7.

CD44 enhances the epithelial-mesenchymal transition in association with colon cancer invasion.

Cho SH, Park YS, Kim HJ, Kim CH, Lim SW, Huh JW, Lee JH, Kim HR.

Int J Oncol. 2012 Jul;41(1):211-8. doi: 10.3892/ijo.2012.1453. Epub 2012 Apr 30.

PMID:
22552741
8.

Cisplatin treatment of primary and metastatic epithelial ovarian carcinomas generates residual cells with mesenchymal stem cell-like profile.

Latifi A, Abubaker K, Castrechini N, Ward AC, Liongue C, Dobill F, Kumar J, Thompson EW, Quinn MA, Findlay JK, Ahmed N.

J Cell Biochem. 2011 Oct;112(10):2850-64. doi: 10.1002/jcb.23199.

PMID:
21618587
9.

Heparin-binding epidermal growth factor-like growth factor promotes transcoelomic metastasis in ovarian cancer through epithelial-mesenchymal transition.

Yagi H, Yotsumoto F, Miyamoto S.

Mol Cancer Ther. 2008 Oct;7(10):3441-51. doi: 10.1158/1535-7163.MCT-08-0417.

10.

CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer.

Tjhay F, Motohara T, Tayama S, Narantuya D, Fujimoto K, Guo J, Sakaguchi I, Honda R, Tashiro H, Katabuchi H.

Cancer Sci. 2015 Oct;106(10):1421-8. doi: 10.1111/cas.12765. Epub 2015 Sep 21.

11.

Hypoxia activated EGFR signaling induces epithelial to mesenchymal transition (EMT).

Misra A, Pandey C, Sze SK, Thanabalu T.

PLoS One. 2012;7(11):e49766. doi: 10.1371/journal.pone.0049766. Epub 2012 Nov 21.

12.

Immunohistological insight into the correlation between neuropilin-1 and epithelial-mesenchymal transition markers in epithelial ovarian cancer.

Adham SA, Al Harrasi I, Al Haddabi I, Al Rashdi A, Al Sinawi S, Al Maniri A, Ba-Omar T, Coomber BL.

J Histochem Cytochem. 2014 Sep;62(9):619-31. doi: 10.1369/0022155414538821. Epub 2014 May 21.

PMID:
24850663
13.

Protein markers of cancer-associated fibroblasts and tumor-initiating cells reveal subpopulations in freshly isolated ovarian cancer ascites.

Wintzell M, Hjerpe E, Åvall Lundqvist E, Shoshan M.

BMC Cancer. 2012 Aug 18;12:359. doi: 10.1186/1471-2407-12-359.

14.

Cross talk of signals between EGFR and IL-6R through JAK2/STAT3 mediate epithelial-mesenchymal transition in ovarian carcinomas.

Colomiere M, Ward AC, Riley C, Trenerry MK, Cameron-Smith D, Findlay J, Ackland L, Ahmed N.

Br J Cancer. 2009 Jan 13;100(1):134-44. doi: 10.1038/sj.bjc.6604794. Epub 2008 Dec 16.

15.

Isolation and characterization of stromal progenitor cells from ascites of patients with epithelial ovarian adenocarcinoma.

Ho CM, Chang SF, Hsiao CC, Chien TY, Shih DT.

J Biomed Sci. 2012 Feb 14;19:23. doi: 10.1186/1423-0127-19-23.

16.

The epithelial-mesenchymal transition and the estrogen-signaling in ovarian cancer.

Gallo D, Ferlini C, Scambia G.

Curr Drug Targets. 2010 Apr;11(4):474-81. Review.

PMID:
20015012
17.

Mesenchymal-to-epithelial transition determinants as characteristics of ovarian carcinoma effusions.

Elloul S, Vaksman O, Stavnes HT, Trope CG, Davidson B, Reich R.

Clin Exp Metastasis. 2010 Mar;27(3):161-72. doi: 10.1007/s10585-010-9315-2. Epub 2010 Mar 7.

PMID:
20213325
18.

Analysis of epithelial and mesenchymal markers in ovarian cancer reveals phenotypic heterogeneity and plasticity.

Strauss R, Li ZY, Liu Y, Beyer I, Persson J, Sova P, Möller T, Pesonen S, Hemminki A, Hamerlik P, Drescher C, Urban N, Bartek J, Lieber A.

PLoS One. 2011 Jan 14;6(1):e16186. doi: 10.1371/journal.pone.0016186. Erratum in: PLoS One. 2011;6(2). doi: 10.1371/annotation/8c637352-3614-406c-89dc-e78d10fa069c.

19.

Suppression of the epidermal growth factor receptor inhibits epithelial-mesenchymal transition in human pancreatic cancer PANC-1 cells.

Chang ZG, Wei JM, Qin CF, Hao K, Tian XD, Xie K, Xie XH, Yang YM.

Dig Dis Sci. 2012 May;57(5):1181-9. doi: 10.1007/s10620-012-2036-4. Epub 2012 Jan 21.

PMID:
22271412
20.

The miR-200 family regulates the epithelial-mesenchymal transition induced by EGF/EGFR in anaplastic thyroid cancer cells.

Zhang Z, Liu ZB, Ren WM, Ye XG, Zhang YY.

Int J Mol Med. 2012 Oct;30(4):856-62. doi: 10.3892/ijmm.2012.1059. Epub 2012 Jul 12.

PMID:
22797360
Items per page

Supplemental Content

Write to the Help Desk